Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Public ClinicalTrials.gov record NCT01543152. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART
Study identification
- NCT ID
- NCT01543152
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Sangamo Therapeutics
- Industry
- Enrollment
- 26 participants
Conditions and interventions
Conditions
Interventions
- SB-728-T Genetic
Genetic
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2011
- Primary completion
- Jul 6, 2017
- Completion
- Jul 6, 2017
- Last update posted
- May 23, 2021
2011 – 2017
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Care Center | Los Angeles | California | 90035 | — |
| Quest Clinical Research | San Francisco | California | 94115 | — |
| Circle CARE Center, LLC | Norwalk | Connecticut | 06850 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| Central West Clinical Research, Inc. | St Louis | Missouri | 63108 | — |
| Southwest CARE Center | Santa Fe | New Mexico | 87505 | — |
| Ricky K Hsu, MD, PC | New York | New York | 10011 | — |
| Central Texas Clinical Research | Austin | Texas | 78705 | — |
| North Texas Infectious Diseases Consultants | Dallas | Texas | 75246 | — |
| Gordon Crofoot, MD, PA | Houston | Texas | 77098 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01543152, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 23, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01543152 live on ClinicalTrials.gov.